Literature DB >> 1996736

Characteristics of natural antibody responses to the circumsporozoite protein of Plasmodium vivax.

A E Brown1, H K Webster, K Krinchai, D M Gordon, R A Wirtz, B Permpanich.   

Abstract

The antibody response to the prototype circumsporozoite (CS) protein of Plasmodium vivax (CSPV) was studied in Thai soldiers experiencing occupational malaria. Seventy-four (65%) of 114 men followed during assignment to a malaria transmission area developed blood-stage infection with P. vivax. IgG antibodies against the central repeat region of the CSPV protein were quantitated by ELISA using the recombinant protein, NS181V20, as the capture antigen. One quarter of the subjects had detectable anti-CSPV antibodies at the beginning of the study. CSPV antibody seroconversion was documented in 16 of 26 subjects assessed during their first observed episodes of vivax malaria. This antibody response was of moderate magnitude, fell off after the first week post-diagnosis and appeared, at the low levels observed, to be unassociated with protection. Continued assessment of anti-CSPV antibody after subjects left the transmission area found no increase associated with release of P. vivax. These findings indicate that CS antibody responses to P. vivax during occupational malaria share many characteristics with responses to P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996736     DOI: 10.4269/ajtmh.1991.44.21

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens.

Authors:  K C Kain; A E Brown; H K Webster; R A Wirtz; J S Keystone; M H Rodriguez; J Kinahan; M Rowland; D E Lanar
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.

Authors:  Peter Van den Eede; Veronica E Soto-Calle; Christopher Delgado; Dionicia Gamboa; Tanilu Grande; Hugo Rodriguez; Alejandro Llanos-Cuentas; Jozef Anné; Umberto D'Alessandro; Annette Erhart
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

3.  Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study.

Authors:  Michele D Spring; Sathit Pichyangkul; Chanthap Lon; Panita Gosi; Kosol Yongvanichit; Utaiwan Srichairatanakul; Amporn Limsalakpeth; Chaiyaporn Chaisatit; Soklyda Chann; Sabaithip Sriwichai; Montida Auayapon; Suwanna Chaorattanakawee; Sheetij Dutta; Satharath Prom; Char Meng Chour; Douglas S Walsh; Evelina Angov; David L Saunders
Journal:  Malar J       Date:  2016-01-08       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.